Nucleus Genomics’ Post

Huge milestone for Nucleus! We’re pushing genetic health into the future. Here’s what’s next:

View profile for Kian Sadeghi

Founder, CEO at Nucleus | Building the future of genomics

$14M raised. But this is bigger than a fundraise - this is about where we’re headed. Whole-genome sequencing is getting cheaper. AI is getting smarter. And Nucleus is turning these shifts into genetic insights that actually drive action. We’re rewriting family planning, building something that has never existed before. Nucleus will help anyone, anywhere, have healthy children. The next six months will prove it.

Britt Moses

Director Business Development

1mo

Huge! congrats!

Like
Reply
Nonye Umahi

Managing Consultant at Cuanu Consult | ISO15189, Training, Health, Management and HR Expert; & Certified Business Development Service Provider

2mo

Amazing!

Zane Aridi

Founder of Imagine Software Consultancy | Grad Advisor for Imagine Software Club @ MSU

1mo

What an incredible mission, would that even include being able to help couples who may struggle with HIV to have healthy children?

Like
Reply
Natalie Dayan

Investment Analyst | Venture Capital | Healthcare & Technology Enthusiast | USC Alum

2mo

This is big! Onwards and upwards from here

CHRISTOS MICHAIL

Area Sales Manager at Remedica Ltd

1mo

Well done Kian. We need such brains in our days and i wish you all the best. However, I have the following questions if you can give me an answer for better understanding. 1.Genetic tests reveal predispositions but can't predict diseases with certainty. Nucleus Genomics offers insights into health risks, factors like environment and lifestyle play a major role. How does Nucleus Genomics bridge the gap between genetic predisposition and real-world disease manifestation to enhance predictive accuracy? 2. As whole-genome sequencing becomes more accessible, the challenge shifts from data acquisition to interpretation. How does Nucleus Genomics differentiate itself in leveraging AI, machine learning, or partnerships to provide truly actionable insights rather than just raw genetic probabilities? 3. With the growing accessibility of whole-genome sequencing, how does Nucleus Genomics address the ethical concerns of genetic determinism, data privacy, and the potential psychological impact of revealing high-risk disease predispositions to individuals?

See more comments

To view or add a comment, sign in

Explore topics